OptimizeRx Corp: chief business officer Andrew J. D'Silva sold 414 shares

What happened The Form 4 reports that Andrew J. D'Silva, chief business officer, had 414 shares withheld to satisfy tax withholding upon vesting of restricted stock units. The shares were withheld at $8.39 per share, for a total of $3,473, on Oct 1, 2026 (transaction code F).

Key details

• Transaction date and price: Oct 1, 2026; $8.39 per share.
• Transaction type/code: F (payment of exercise price or tax liability; treated as a disposition).
• Shares owned after the transaction: not reported in this filing.
• Footnote: "These shares were withheld by the Issuer upon the vesting of restricted stock units to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended." (Footnote F1)
• Filing date: Oct 2, 2026; the filing does not indicate a late filing.

Why it may matter

• This filing shows shares were withheld by the issuer to cover tax obligations on vested restricted stock units, not a market sale by the reporting person. A filing does not show why the insider traded or why the company acted.